The company plans to use the new financing to expand its cardiac monitoring business line and partner with more hospitals. Revelation Partners led the financing round, according to a July 18 VitalConnect news release.
VitalConnect produces biosensors designed to be used for monitoring in an inpatient setting. The company is expecting to achieve profitability in 2024.
“This latest round of financing, at an increased valuation, signals unwavering support from our investors while providing the company the runway needed to achieve our goal of being the world’s leading provider of remote patient monitoring solutions,” VitalConnect CEO Peter Van Haur said in the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.